FDA Memorandum Circular No. 2013-024
In the interest of public service
delivery, with respect to the payment of corresponding fees, Procedure
Nos. 5, 6, 6.1 and 6.2 of FDA Memorandum Circular No. 2013-16 are hereby
amended as follows:
Procedure No. 5 to read as:
"Pay the corresponding fee at any
DBP branch using the Account Name: Food and Drug Administration Special
Fund, Account No.: DBP 0430-013669-030. The ASSESSMENT FORM xxx..."
Procedure No. 6, 6.1 and 6.2 to delete the words: "Original Receipt (OR)"
Likewise, Validated Deposit Slip is
considered as proof of payment; hence, issuance of Official Receipt (OR)
in the FDA is no longer necessary.
All other provisions of FDA Memorandum Circular No. 2013-16 are still in effect.
See Complete Information Here:
